Page last updated: 2024-09-03

imatinib mesylate and Plica Syndrome

imatinib mesylate has been researched along with Plica Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baeten, D; Caňete, JD; Gofita, I; Noordenbos, T; Tak, PP; van de Sande, M; Yeremenko, N	1

Other Studies

1 other study(ies) available for imatinib mesylate and Plica Syndrome

Article	Year
Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis and rheumatism, 2012, Volume: 64, Issue:1 Topics: Adult; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; Benzamides; Cell Degranulation; Cells, Cultured; Female; Gene Expression; Humans; Imatinib Mesylate; Interleukin-17; Male; Mast Cells; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA, Messenger; Spondylarthritis; Synovial Fluid; Synovial Membrane; Synovitis; Young Adult	2012

Article

Year

Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.

Arthritis and rheumatism, 2012, Volume: 64, Issue:1

Topics: Adult; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; Benzamides; Cell Degranulation; Cells, Cultured; Female; Gene Expression; Humans; Imatinib Mesylate; Interleukin-17; Male; Mast Cells; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA, Messenger; Spondylarthritis; Synovial Fluid; Synovial Membrane; Synovitis; Young Adult

2012